Alex Zhavoronkov: Coming to Shanghai FTZ was the best decision for me
[Video provided to english.pudong.gov.cn]
Alex Zhavoronkov is the founder and CEO of Insilico Medicine. In 2018, he made the decision to establish his company's drug R&D headquarters in Zhangjiang. Within just four years of development, his company has already produced 14 preclinical drug candidates and three drugs that have entered clinical trials. Alex has also witnessed the tremendous transformation of China over the past 20 years, which has greatly astonished him. What are his future development goals? Click the video to learn more!